BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 58 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -33.3% | 300,000 | 0.0% | 0.06% | +31.1% |
| Q2 2022 | $27,000 | -62.5% | 300,000 | 0.0% | 0.04% | -58.7% |
| Q1 2022 | $72,000 | -63.6% | 300,000 | 0.0% | 0.11% | -56.2% |
| Q4 2021 | $198,000 | 0.0% | 300,000 | 0.0% | 0.25% | +25.8% |
| Q3 2021 | $198,000 | -23.3% | 300,000 | 0.0% | 0.20% | +28.6% |
| Q2 2021 | $258,000 | +72.0% | 300,000 | +20.0% | 0.15% | +196.2% |
| Q1 2021 | $150,000 | – | 250,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 202,950 | $2,049,775 | 0.06% |
| RAMIUS ADVISORS LLC | 569,526 | $36,392 | 0.04% |
| Telemetry Investments, L.L.C. | 153,694 | $10 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,493 | $610,973 | 0.01% |
| MARSHALL WACE, LLP | 575,000 | $5,807,501 | 0.01% |
| Corbin Capital Partners, L.P. | 464,062 | $29,654 | 0.01% |
| Q Global Advisors, LLC | 300,000 | $19 | 0.01% |
| Segantii Capital Management Ltd | 25,000 | $252,000 | 0.01% |
| LMR Partners LLP | 50,000 | $504,995 | 0.01% |
| HGC Investment Management Inc. | 2,429,166 | $151 | 0.01% |